Oracle Customer Care up to 12.2.15 Internal Operations privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.3 | $5k-$25k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Oracle Customer Care up to 12.2.15. This vulnerability affects unknown code of the component Internal Operations. Such manipulation leads to privileges management. This vulnerability is traded as CVE-2026-60920. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability was found in Oracle Customer Care up to 12.2.15. It has been rated as critical. Affected by this issue is some unknown functionality of the component Internal Operations. The manipulation with an unknown input leads to a privileges management vulnerability. Using CWE to declare the problem leads to CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. Impacted is confidentiality, integrity, and availability. CVE summarizes:
Vulnerability in the Oracle Customer Care product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Customer Care. Successful attacks of this vulnerability can result in takeover of Oracle Customer Care. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared for download at oracle.com. This vulnerability is handled as CVE-2026-60920 since 07/08/2026. The exploitation is known to be easy. The attack may be launched remotely. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $5k-$25k (estimation calculated on 07/22/2026). The MITRE ATT&CK project declares the attack technique as T1068.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
- 12.2.0
- 12.2.1
- 12.2.2
- 12.2.3
- 12.2.4
- 12.2.5
- 12.2.6
- 12.2.7
- 12.2.8
- 12.2.9
- 12.2.10
- 12.2.11
- 12.2.12
- 12.2.13
- 12.2.14
- 12.2.15
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/08/2026 CVE reserved07/22/2026 Advisory disclosed
07/22/2026 VulDB entry created
07/22/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-60920 (🔒)
GCVE (CVE): GCVE-0-2026-60920
GCVE (VulDB): GCVE-100-381824
Entry
Created: 07/22/2026 06:05Changes: 07/22/2026 06:05 (52)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.